Pascal Deschatelets
Chief Scientific Officer · Apellis Pharmaceuticals, Inc.
- 2026
- May 14, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Pascal Deschatelets files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Cedric Francois - $980K in APLS purchases and sales in the last 12 months
- David O. Watson - $697K in APLS purchases and sales in the last 12 months
- Timothy Eugene Sullivan - $647K in APLS purchases and sales in the last 12 months
- Nur Nicholson - $270K in APLS purchases and sales in the last 12 months
- Caroline Baumal - $175K in APLS purchases and sales in the last 12 months
- Mark Jeffrey Delong - $147K in APLS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Pascal Deschatelets?
Pascal Deschatelets is a corporate insider, tracked as Chief Scientific Officer of Apellis Pharmaceuticals, Inc. (APLS). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Pascal Deschatelets last file a Form 4?
The most recent primary Form 4 on record is dated 14 May 2026, one of 5 filings going back to 2026.
Has Pascal Deschatelets been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($198K) across all tracked filings.
